Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental Glomerulosclerosis

NCT00883636 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT00883636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00883636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental Glomerulosclerosis
Lead sponsor
Northwell Health
Phase
Observational
Overall status
Terminated
Start date
October 31, 2008
Completion date
October 31, 2011
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, focal segmental glomerulosclerosis, nephrotic syndrome, steroid resistant nephrotic syndrome